Profound Medical Corp. (PRN)
TSX
Closed
Nov 6, 2026
Day's Range
8.6052 wk Range
6.52Overview - PRN - Profound Medical Corp.
Key Statistics
Valuation
Enterprise Value
355.25M
P/E (Trailing)
-5.56
P/E (Forward)
-9.40
PEG Ratio
0.11
Price / Sales (TTM)
14.91
Price / Book
4.06
EV / EBITDA
-7.27
Profitability
Gross Margin
78.41%
Profit Margin
-171.56%
Operating Margin
-445.67%
Return on Assets
-39.45%
Return on Equity
-73.52%
Ownership
Shares Outstanding
36.53M
Float
35.50M
Short % of Shares Outstanding
0.97%
Held by Insiders
4.08%
Held by Institutions
45.14%
Price stats
Beta
0.55
50-Day Avg
8.84
200-Day Avg
9.35
Analyst Consensus
5 analysts
Market Cap - PRN - Profound Medical Corp.
Peers - PRN - Profound Medical Corp.
Peer Comparison
Compared with companies in Medical Devices listed on TSX.
Profile Summary - PRN - Profound Medical Corp.
About
Profound Medical Corp. is a commercial-stage medical device company focused on developing and marketing incision-free therapeutic systems for image-guided ablation of diseased tissue. Its flagship TULSA-PRO system combines real-time MRI, AI-assisted planning, robotically driven transurethral ultrasound, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
